Tags : Non-Exclusive Licensing Agreement

Bayer Signs a Non-Exclusive Licensing Agreement with ProteoNic Biotechnology for

Shots: Bayer to get non-exclusive WW license rights to develop and commercialize its own products by using ProteoNic’s 2G UNic Technology  The focus of the collaboration is to produce and enhance Bayer recombinant proteins portfolio utilizing ProteoNic’s 2G UNic Technology ProteoNic’s 2G UNic Technology is a protein expression technology designed to improve cell line production […]Read More